During the past decade, Wojewódzki Szpital Specjalistyczny Nr 3 conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewódzki Szpital Specjalistyczny Nr 3" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Bayer" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Morphotek" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewódzki Szpital Specjalistyczny Nr 3" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wojewódzki Szpital Specjalistyczny Nr 3" are "Gastric Cancer" (2 trials), "Multiple Sclerosis" (2 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Wojewódzki Szpital Specjalistyczny Nr 3" in a lesser frequency.

Most popular intervention types in "Wojewódzki Szpital Specjalistyczny Nr 3" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Placebo" (3 trials), "Pertuzumab" (2 trials), "Taxane" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewódzki Szpital Specjalistyczny Nr 3" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wojewódzki Szpital Specjalistyczny Nr 3". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wojewódzki Szpital Specjalistyczny Nr 3, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewódzki Szpital Specjalistyczny Nr 3, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".